Latest News & Features
Americas
GSK revealed its new approach to research and development earlier this week, including a partnership with DNA testing company 23andMe. 27 July 2018
Asia
Changyu Shen was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 27 July 2018
Biotechnology
Genome-editing techniques, including CRISPR/Cas9, will be subject to more stringent regulations after a ruling from Europe’s highest court yesterday. 26 July 2018
Asia
In India, a non-profit organisation and an advocacy group have united to take on a patent covering pibrentasvir, part of the drug combination that forms AbbVie’s hepatitis C product Mavyret. 26 July 2018
Americas
Donald Trump was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 26 July 2018
Big Pharma
Earlier today, the Court of Justice of the European Union clarified when a product is ‘protected by a basic patent’ within the meaning of article 3(a) of the SPC regulation. 25 July 2018
Americas
California-based Sangamo Therapeutics has acquired biotech company TxCell for approximately €72 million. 25 July 2018
Americas
Bernard Tyson was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 25 July 2018
Africa
Tedros Ghebreyesus was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 24 July 2018
Americas
The Patent Trial and Appeal Board has rejected another challenge to a Gilead-owned patent covering the company’s hepatitis C medicines. 24 July 2018